Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
| dc.authorid | 0000-0003-2538-8569 | |
| dc.contributor.author | Şenocak Taşçı, Elif | |
| dc.contributor.author | Oyan, Başak | |
| dc.contributor.author | Sönmez, Özlem | |
| dc.contributor.author | Mutlu, Arda Ulaş | |
| dc.contributor.author | Atçı, Muhammed Mustafa | |
| dc.contributor.author | Sakin, Abdullah | |
| dc.contributor.author | Öner, İrem | |
| dc.contributor.author | Yeşil Çınkır, Havva | |
| dc.contributor.author | Bozkurt, Mustafa | |
| dc.date.accessioned | 2024-02-13T07:03:05Z | |
| dc.date.available | 2024-02-13T07:03:05Z | |
| dc.date.issued | 2024 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Onkoloji Ana Bilim Dalı | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.citation | Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. ... Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0 | |
| dc.identifier.doi | 10.1186/s12885-024-11863-0 | |
| dc.identifier.issn | 1471-2407 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 38262962 | |
| dc.identifier.uri | https://dx.doi.org/10.1186/s12885-024-11863-0 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/12264 | |
| dc.identifier.volume | 24 | |
| dc.identifier.wos | 001148300200002 | en_US |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | Sakin, Abdullah | |
| dc.language.iso | en | |
| dc.publisher | BMC | |
| dc.relation.ispartof | BMC Cancer | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | Attribution 4.0 International | * |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Metastatic Colorectal Cancer | |
| dc.subject | Chemotherapy | |
| dc.subject | Regorafenib | |
| dc.subject | Third-Line Treatment | |
| dc.title | Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024) | |
| dc.type | Article |
